Jason Haas, CFO: Odyssey Therapeutics ODTX Buy · Filed 05/11

Trade details

Type: Insider buy
Amount: $20,000
Shares · price: 1,000 sh · $20.00 a share
Held after: 62,908 sh
Stock: Odyssey Therapeutics ODTX
Person: Jason HaasCFO
Trade date: 26/05/08
Filed: 26/05/11
Days to filing: 3 days

First buy since 2023

Insiders buying this week: 10 insiders
Holding change: +1.6%

Odyssey Therapeutics trades, last 26 weeks

What else happened in Odyssey Therapeutics around then

Filed or reported within 30 days of the trade day · 04/08~06/07

Jason Haas's recent trades

Jason HaasDirector
Planned saleLigand Pharmaceuticals
Planned sale
Ligand Pharmaceuticals
LGND
$2.1M
7,138 sh
$2.1M
Filed 08/12
Traded 08/12
Jason HaasDirector
SellLigand Pharmaceuticals
Sell
Ligand Pharmaceuticals
LGND
$886.3K
3,461 sh
$886.3K
Filed 06/15
Traded 06/12
Jason HaasDirector
SellLigand Pharmaceuticals
Sell
Ligand Pharmaceuticals
LGND
$765K
3,000 sh
$765K
Filed 06/15
Traded 06/12
Jason HaasDirector
Planned saleLigand Pharmaceuticals
Planned sale
Ligand Pharmaceuticals
LGND
$1.7M
6,461 sh
$1.7M
Filed 06/12
Traded 06/12
Jason HaasCFO
SellSyros Pharmaceuticals
Sell
Syros Pharmaceuticals
SYRS
$28.9K
137,803 sh
$28.9K
Filed 24/11/20
Traded 24/11/18